• Launched a healthcare services initiative to expand into a broader, revenue-generating healthcare enterprise.
• Evaluating acquisitions of a management services organization and a contract research organization to build recurring revenue.
• Targets about $100 million in combined annual revenue from the potential deals.
• William Keane named interim head to lead planning and assessment of the acquisition pipeline.
• Positions the initiative to complement existing biotechnology and artificial intelligence efforts while supporting long-term financial self-sufficiency.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tevogen Bio Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606091530PRIMZONEFULLFEED9734362) on June 09, 2026, and is solely responsible for the information contained therein.